Hosted on MSN38m
Cantor Fitzgerald Downgrades Keros Therapeutics (KROS)Fintel reports that on January 21, 2025, Cantor Fitzgerald downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback